FY2025 EPS Estimate for Trulieve Cannabis Reduced by Analyst

Trulieve Cannabis Corp. (TSE:TRU) – Research analysts at Cormark cut their FY2025 EPS estimates for Trulieve Cannabis in a note issued to investors on Monday, November 10th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of ($0.46) per share for the year, down from their prior forecast of ($0.40). Cormark also issued estimates for Trulieve Cannabis’ FY2026 earnings at $0.15 EPS.

Trulieve Cannabis Stock Performance

About Trulieve Cannabis

TRU (TSXV:TRU; OTCQB:TRUIF) is on a mission to build long-term shareholder value, through prudent natural resource property development and transactions. TRU is exploring for gold and copper in the highly prospective Central Newfoundland Gold Belt on its 100%-owned Golden Rose Project, originally optioned from TSX-listed Altius Minerals.